-
Most Popular
Earnings Reports
XP Stock Earnings: XP Beats EPS, Beats Revenue for Q2 2024
XP stock results show that XP beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
QUIK Stock Earnings: QuickLogic Misses Revenue for Q2 2024
QUIK stock results show that QuickLogic missed on revenue for the second quarter of 2024.
BEEM Stock Earnings: Beam Glb Misses EPS, Misses Revenue for Q2 2024
BEEM stock results show that Beam Glb missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
NVVE Stock Earnings: Nuvve Holding Reported Results for Q2 2024
Nuvve Holding just reported results for the second quarter of 2024.
USPH Stock Earnings: US Physical Therapy Misses EPS, Beats Revenue for Q2 2024
USPH stock results show that US Physical Therapy missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
QMCO Stock Earnings: Quantum Meets EPS, Misses Revenue for Q1 2025
QMCO stock results show that Quantum met analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q2 2024
VALN stock results show that Valneva missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
BNTGY Stock Earnings: Brenntag Reported Results for Q2 2024
Brenntag just reported results for the second quarter of 2024.
BRN Stock Earnings: Barnwell Industries Reported Results for Q3 2024
Barnwell Industries just reported results for the third quarter of 2024.
XXII Stock Earnings: 22nd Century Group Misses Revenue for Q2 2024
XXII stock results show that 22nd Century Group missed on revenue for the second quarter of 2024.
CNTA Stock Earnings: Centessa Pharmaceuticals Misses EPS for Q2 2024
CNTA stock results show that Centessa Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024
JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024
RPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024
ATAI stock results show that ATAI Life Sciences missed analyst estimates for earnings per share the second quarter of 2024.
VIGL Stock Earnings: Vigil Neuroscience Beats EPS for Q2 2024
VIGL stock results show that Vigil Neuroscience beat analyst estimates for earnings per share the second quarter of 2024.
TRDA Stock Earnings: Entrada Therapeutics Beats EPS, Beats Revenue for Q2 2024
TRDA stock results show that Entrada Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024.
IOBT Stock Earnings: IO Biotech Beats EPS for Q2 2024
IOBT stock results show that IO Biotech beat analyst estimates for earnings per share the second quarter of 2024.
